Saturday, October 1, 2022
Published 2 Years Ago on Sunday, Jun 21 2020 By Mounir Jamil
A widely available and relatively cheap drug can apparently save the lives of patients who have been seriously ill from coronavirus. Dexamethasone, is reportedly part of the world’s biggest trial, testing existing treatments to find out whether they work as effectively on patients with Covid-19.
During the trial, led by a team at Oxford University, about 2,000 hospital patients were given dexamethasone compared with 4,000 patients who were not. For patients that were on ventilators, it reduced the risk of death from 40% to 28% and for patients in need of oxygen, it reduced the risk from 25% to 20%.
Dexamethasone is a steroid that has been well known since the early 1960s. The drug has been widely used to treat a range of conditions such as asthma, arthritis, and some skin conditions. It also appears to help some of the damage that occurs when the body’s immune system tries to fight diseases. The overreaction known as a cytokine storm can be lethal.
However, dexamethasone, doesn’t seem to help people with milder symptoms of coronavirus who do not have breathing problems. The trial that has been running since March, also examined the malaria drug hydroxychloroquine, which has since been dropped from trials amid concerns that it increases risk of fatalities and heart problems.
It is a great point of frustration for many of today’s youth that while the rest of the world’s industries and sectors are digitized and evolving with time, the education system feels stuck in the 1920s – at least outside of developed countries. Many parents and children alike are yearning for a more futuristic education […]
Stay tuned with our weekly newsletter on all telecom and tech related news.
© Copyright 2022, All Rights Reserved